Capital Asset Advisory Services LLC Has $2.35 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Asset Advisory Services LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,051 shares of the medical equipment provider’s stock after purchasing an additional 356 shares during the quarter. Capital Asset Advisory Services LLC’s holdings in Intuitive Surgical were worth $2,350,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Baystate Wealth Management LLC boosted its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC boosted its stake in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares in the last quarter. Headinvest LLC acquired a new stake in Intuitive Surgical in the third quarter valued at about $28,000. Able Wealth Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Stone House Investment Management LLC boosted its stake in Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.1 %

NASDAQ ISRG traded down $0.26 during trading hours on Friday, hitting $444.85. 3,106,093 shares of the company’s stock were exchanged, compared to its average volume of 1,525,986. The stock has a 50-day simple moving average of $400.81 and a 200 day simple moving average of $381.34. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $447.11. The firm has a market cap of $157.79 billion, a price-to-earnings ratio of 80.34, a PEG ratio of 5.72 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the firm posted $1.00 earnings per share. The firm’s revenue was up 11.5% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 1,498 shares of the firm’s stock in a transaction that occurred on Friday, April 26th. The shares were sold at an average price of $369.92, for a total value of $554,140.16. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The disclosure for this sale can be found here. Insiders sold 17,956 shares of company stock valued at $6,927,011 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on ISRG. Piper Sandler raised their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Jefferies Financial Group increased their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. BTIG Research increased their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $403.67.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.